Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries AbbVie (NY: ABBV ) 168.59 +2.03 (+1.22%) Official Closing Price Updated: 7:00 PM EDT, Jun 14, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about AbbVie < Previous 1 2 3 4 5 6 7 Next > AbbVie continues shopping spree with biotech buyout December 12, 2023 While the diversifying AbbVie appears to be in a state of flux, there is one constant investors can depend on — the dividend. Via MarketBeat BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc. (Nasdaq – CERE), ImmunoGen, Inc. (Nasdaq – IMGN), Graphite Bio, Inc. December 11, 2023 From Brodsky & Smith LLC Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Hawaiian Holdings, Inc. (Nasdaq – HA), ImmunoGen, Inc. (Nasdaq – IMGN), Graphite Bio, Inc. (Nasdaq – GRPH), CapStar Financial Holdings, Inc. (Nasdaq – CSTR) December 04, 2023 From Brodsky & Smith LLC Via GlobeNewswire AbbVie Inc. (NYSE: ABBV) Highlighted for Surprising Price Action October 30, 2023 Via Investor Brand Network Doing Your Holiday Shopping? These Stocks Might Make Great Gifts December 04, 2023 No matter which holiday you're planning gifts for, Christmas, Hanukkah, or some other occasion, there may be one great gift idea you haven't thought of yet. Via MarketBeat Topics Bonds Exposures Debt Markets These biotechs targeting multiple neurodegenerative diseases December 01, 2023 A growing number of up-and-coming biotech firms are demonstrating the value of expanding a drug's total addressable market. Via MarketBeat AbbVie Inc. (NYSE: ABBV) Highlighted for Surprising Price Action July 14, 2023 Via Investor Brand Network AbbVie Inc. (NYSE: ABBV) Making Surprising Moves in Monday Session April 24, 2023 Via Investor Brand Network These are the top sectors for blue chip growth in 2024 November 29, 2023 The sector results will be mixed in 2024 but the Health Care, Communications and Technology sectors (and some of their stocks) will post robust gains. Via MarketBeat Topics Economy Intellectual Property Exposures COVID-19 Intellectual Property Interest Rates J&J, Gilead, BMS: A look at undervalued dividend payers November 29, 2023 J&J, Gilead and Bristol Myers are among healthcare stocks with defensive qualities amid market volatility and a potential economic slowdown Via MarketBeat Guidance leads the market for these stocks; 1 raises, 1 lowers November 07, 2023 Guidance is a driving force for equity markets and can lead stock prices higher or lower, catalyze significant moves, and alter analysts' outlook Via MarketBeat Investor patience tested as pharmaceutical stocks take a tumble November 01, 2023 The healthcare sector faces a selloff as pharmaceutical giants report lackluster earnings; even Amgen's strong results failed to prevent selling in the sector Via MarketBeat J&J stock down as business unit mulls talc-related bankruptcy October 31, 2023 Johnson & Johnson stock fell in the past week as talc-related lawsuits weigh on a subsidiary, which is mulling bankruptcy to mitigate payouts and settlements. Via MarketBeat Topics Bankruptcy Lawsuit Exposures Financial Legal High-yield, deep-value AbbVie fell off the patent cliff and lived October 27, 2023 AbbVie's deep value and high yield attract income investors, and the patent cliff worry lessens daily. Via MarketBeat Topics Intellectual Property Exposures Intellectual Property Clorox Pullback Presents a Chance to Clean Up on a 3.6% Dividend September 26, 2023 The Clorox Company's 44% two-year plunge has created an opportunity to own a defensive stock with a shiny 3.6% dividend. Via MarketBeat Rising Number of Studies to Develop Novel Therapies For Pancreatic Ductal Adenocarcinoma (PDAC) Intensely Increasing October 23, 2023 EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:CRDF),(NYSE:LLY),(NYSE:ABBV),(NASDAQ:LIPO) EQNX::TICKER_END Via FinancialNewsMedia Topics Death Exposures Death Argenx's 28% Surge & Promising Product Propel Investor Confidence September 25, 2023 Argenx's chart is forming a bullish base after a 28% jump after positive clinical trials. Analysts believe the immunology specialist is an acquisition target. Via MarketBeat Flee to Healthcare Stocks if Recession Rears its Head? September 20, 2023 In uncertain economic conditions, healthcare stocks can be a refuge due to steady demand and favorable inflation conditions. Many also offer dividends. Via MarketBeat Topics Economy Exposures Economy Interest Rates The Breakthrough Therapy Aiming To Solve The World’s Mental Health Crisis September 19, 2023 EQNX::TICKER_START (NYSE:JNJ),(NYSE:ABBV),(NASDAQ:ATAI),(NASDAQ:CMPS),(NASDAQ:MNMD) EQNX::TICKER_END Via FinancialNewsMedia Topics Economy Exposures Economy Product Safety High Yield, Low Beta Stocks to Buy for the Next Market Meltdown September 12, 2023 The market is set up for a fall, and it may start soon, as soon as the CPI data is released. These low-beta stocks are poised to outperform and pay dividends Via MarketBeat Topics Economy Stocks Exposures Economy Interest Rates US Equities Alector Announces Completion of Enrollment in the INVOKE-2 Phase 2 Clinical Trial of AL002, a TREM2 Monoclonal Antibody, in Individuals With Early Alzheimer’s Disease September 07, 2023 Data readout expected in Q4 2024 From Alector, Inc. Via GlobeNewswire A Significant Reversal is in Sight for These 5 Med Tech Companies August 30, 2023 Med tech stocks are down YOY despite strong secular tailwinds, cash flow, and dividends; the downturn in action is an opportunity and reversal is at hand. Via MarketBeat 5 Best Stocks to Buy in a Bear Market August 11, 2023 Want income-producing assets and stable stocks? Look for stocks with stable cash flow in rock-solid industries for the best stocks to buy in a bear market. Via MarketBeat Topics Economy Exposures Economy 3 Pharmaceutical Stocks to Buy and Hold for the Long Haul August 11, 2023 Robust pipelines make these three pharmaceutical stocks solid choices for investors looking for stocks to buy and hold for long-term gains Via MarketBeat Exposures COVID-19 Is Growth Priced into Amgen Stock after Earnings Beat? August 07, 2023 Amgen earnings delivered a solid earnings report after the market closed but analyst sentiment suggests that growth may already be priced into AMGN stock. Via MarketBeat The Patent Cliff Is Why AbbVie Is Moving Higher July 28, 2023 High-yielding AbbVie will retest the all-time high after posting a solid quarter underpinned by new treatments and relative strength in Humira. Via MarketBeat Topics Intellectual Property Exposures Intellectual Property 3 Dividend Stocks That Still Make Sense in 2023 July 17, 2023 Investors are still faced with an uncertain market which is favorable for these three dividend stocks regardless of what happens in the economy Via MarketBeat Topics Economy Exposures Economy High-Yield Pfizer Falls Off The COVID Cliff, And Survives May 02, 2023 Pfizer is a value and high-yield compared to its peers and it it outperforming expectations in 2023; The pipeline is robust. Via MarketBeat Topics Intellectual Property Exposures COVID-19 Intellectual Property Hagens Berman: Class Action Accuses AbbVie Inc. of Unfair Pricing of Autoimmune Drug Humira Following 470% Cost Increase April 26, 2023 From Hagens Berman Sobol Shapiro LLP Via Business Wire Why Next Week's Earnings Report is Good for Johnson & Johnson April 13, 2023 Investors have had to digest some negative news headlines, but if you look past that a dividend king like JNJ can be a boring but reliable buy in this market Via MarketBeat Topics Intellectual Property Exposures Intellectual Property < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.